Articles related to CARDIOVASCULAR RISK

According to one review, cardiovascular risk in HoFH is driven not solely by LDL cholesterol levels at a single point in time, but by cholesterol burden over time, or the total lifetime exposure to LDL cholesterol.

“The art now is to match the intensity of treatment to both global cardiovascular risk and the patient’s blood pressure, rather than chasing a number at all costs.” – Dr. Carolyn Lam, National Heart Center of Singapore

“There is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop.” – Senior study author Ziyad Al-Aly, MD; Washington University School of Medicine

The researchers discovered that findings among older adults reinforced the guideline shift toward personalized, risk-based care.

“People who maintain low levels of LDL-C and triglycerides at earlier ages are much less likely to develop atherosclerotic disease decades later.” — Pamela B. Morris, MD, FACC, FAHA, guideline writing committee vice-chair

The study highlights the importance of integrated preventive measures, especially for adults with traditional risk factors for CVD. Vaccines may play an important role in preventing the risk of CVD.